Plants have been long scrutinized in the quest for new antibiotics, but no strong antibiotic molecule was ever found. Evidences exist that most phytochemicals have a regulatory or adjuvant effect on other antibacterial compounds, thus promoting a greater therapeutic effect. The current study assessed twenty-eight plants from different families for their antibacterial activity and as adjuvants in antibiotic therapy against Staphylococcus aureus, including methicillin-resistant S. , respectively. Non-antibacterial plants were assessed in combination with ampicillin, oxacillin, ciprofloxacin, erythromycin and tetracycline by a modified disc diffusion test. Methanolic extracts of Acacia dealbata, Prunus spp. plants, Centaurea nigra, Eupatorium cannabium and Buxus sempervirens showed a potentiating effect mostly of ciprofloxacin, erythromycin and tetracycline. B. sempervirens was selected for its potentiating activity and applied against S. aureus biofilms. B.
Introduction
Two major circumstances have accentuated the quest for new antibacterial agents and alternative therapies in the last decades. Primarily, because microbes, due to their incredible and innate adaptability, seem to have at least equal chances for survival as scientists and pharmaceutical industries develop methods to kill them. 3 Multidrug-resistant (MDR) bacteria are responsible for a large number of nosocomial but also community-acquired infections and are spreading all over the globe. 4 Additionally, the limitation of our current arsenal of effective antibiotics accompanied by the lack of new antimicrobial alternatives are prompting the beginning of the "post-antibiotic era", which threats all the achievements of modern medicine.
Since the beginning of mankind plants were undoubtedly the most important source of therapeutic remedies with an enormous range of applications. The earliest records of natural products were depicted from Mesopotamia (2600 B.C.) and included oils from cypress (Cupressus sempervirens) and myrrh (Commiphora species), which are still used today to treat coughs, colds and inflammation. 5 Many plant extracts and their phytochemical constituents are known to have antimicrobial activities. 6 However, it can be rapidly established that this effort of finding individual active antibiotics in plants has been difficult, since the spectrum of activity of purified components is often non-specific (thus toxic) or very narrow, and for sure weaker than compounds from other sources such as fungi and bacteria. 7 However, plants can still fight most of their infections successfully, which proves that plant defence mechanisms are still not well understood.
Plants have faced most of their natural enemies for millions of years which allowed them to co-evolve and learn how to survive to their attacks. 8 In fact, they do not produce single strong antibacterial compounds as their main defence mechanism, but hundreds of structurally different chemicals with a wide range of activity. 4 Some of them are antimicrobial and act synergistically between each other to produce an Page 1 of 14 RSC Advances enhanced effect against the pathogen. Others are nonantimicrobials, but can improve solubility, absorption and stability of the active compounds. At last but not least, some phytochemicals have been associated with an antibiotic adjuvant activity, especially due to the inhibition of the resistance mechanisms from plant pathogens. Efflux pump inhibitors (EPI) produced by plants have been extensively found and reported, [9] [10] [11] [12] as well as inhibitors of PBP2a; such as baicalein, tellimagrandin I, rugosin B and corilagin, 9, 13, 14 among others. The inhibition of the pathogen resistance mechanisms is a strategy already implemented in clinic. Clavulanic acid, which inhibits β-lactamases despite its weak antibacterial activity, combined with amoxicillin has proven to be remarkably effective in controlling a wide range of bacterial infections for two decades. 15 Plants offer an untapped source of such adjuvant compounds. The aim of this study was first to evaluate the ability of a considerable range of different plants belonging to different families (in order to generate chemical variation) for their antibacterial activity against S. aureus strains, including efflux pump overexpressing and MRSA strains. The plants showing no detectable antibacterial activity were then assessed for their antibiotic-potentiation ability with five antibiotics. The antibiotics chosen (ampicillin and oxacillin -β-lactam, ciprofloxacin -fluoroquinolone, erythromycin -macrolide, and tetracycline) have more limited application nowadays due to increased bacterial tolerance. Additionally, since many reports have shown that staphylococcal infections were associated with biofilm formation, the biofilm control activity promoted by one promising plant extract, which was highlighted among the plants species selected, was evaluated as well.
Materials and methods

Plant material
Twenty-eight Portuguese medicinal, invasive and fruit plant species were mostly collected in the region of Trás-os-Montes and Beira Transmontana (Portugal) and characterized by the Botanical Garden from Vila Real (Portugal), (Table 1) . The leaves of all plants were harvested, separated and immediately frozen in liquid N 2 in order to avoid unwanted enzymatic reactions and stored at -20 o C until analysis.
Plant samples preparation and extraction procedure
The plant materials (5 g) were freeze-dried and extracted with 50 mL of MeOH at 30 o C, stirring at 150 rpm for 60 min. The samples were filtrated and re-extracted with 50 mL MeOH for 60 min. The resulting extracts were combined and the solvent was evaporated at low temperature (< 40 ºC) under reduced pressure. The dried MeOH extracts were stored at -20 o C. 
Bacterial strains
Antibiotic-potentiation testing -Checkerboard
The checkerboard assay was performed in order to assess the synergy between antibiotics and those phytochemicals with antibacterial activity. This method was performed according to CLSI guidelines 18 as described in previous studies. Biofilm control experiment B. sempervirens was chosen for its promising antibioticpotentiating activity and evaluated for its ability to control (remove and inactivate) biofilms of S. aureus CECT 976 within 1 h exposure. Biofilms were developed according to a modified microtiter plate test as described previously. 20 Overnight cultures (~10 6 cells mL -1 ) were added to sterile 96-well polystyrene microtiter plates (Orange Scientific, USA) to form biofilms at 37 o C and stirring at 150 rpm for 24 h. Afterwards, the medium was removed and the biofilms were exposed to the antibiotics and to the plant extract individually and in combination at 37 o C and stirring at 150 rpm for 1 h. Antibiotic (compared with DMSO growth control) was also assessed.
Fractionation of active extract of Buxus sempervirens
B. sempervirens leaves (160 g) were extracted with 500 mL of MeOH following the process described above. 27 The plant extracts that did not show any detectable antibacterial activity were further evaluated for antibioticpotentiating activity with five antibiotics by the disc diffusion method. First, the classification of S. aureus strains according to their resistance profile was performed based on the comparison of the MICs/IZDs results and the susceptibility breakpoints of CLSI guidelines, 2 as shown in Table 3 . Table 4 shows when combined with all antibiotics against CECT 976; with ciprofloxacin against SA1199B and erythromycin against strains RN4220 and MJMC001. Ciprofloxacin, erythromycin and tetracycline were potentiated by the plant extracts mentioned even against MRSA. Resistance to these antibiotics can be easily achieved with the expression of efflux pumps from pathogens. 30 Most of these plant extracts may be causing efflux pump inhibition in S. aureus, thus explaining the potentiation of ciprofloxacin, tetracycline and erythromycin. Indeed, the number of plant extracts producing efflux pump inhibitors seems to be considerable, as it is being extensively reported. 9, 10, 31, 32 No plant extract significantly potentiated β-lactam antibiotics, but additive effects were found with B. sempervirens. Therefore, B. sempervirens seems to act as a general potentiator for the several antibiotics, regardless the antibiotic class. Thus, it is possible that a mechanism, not efflux pump related, is inhibited by B. sempervirens extract. Antibiotic potentiation can be reached by compounds that are interfering with other mechanisms of the bacterial cell that not involve drug resistance mechanisms, such as quorumsensing, virulence activation, biofilm formation, adherence to the host tissues, 33 etc. Bacterial biofilms are particularly problematic since they become even more resistant to most available antibiotics. Any effective strategy able to impair biofilm formation or disturb, weaken or disperse its structure is urgently needed and for long desired. The MeOH extract of B. sempervirens was analyzed for its ability to control biofilms of the susceptible strain S. aureus CECT 976, against which the antibiotic combinations with B. sempervirens extract were generally more effective. The MeOH extract of B. sempervirens was evaluated against CECT 976 24 h-old biofilms at several concentrations (Fig. 1) . It is possible to observe an overall concentrationdependent effect, and increasing concentrations of B. sempervirens extract caused high biofilm removal (P < 0.05), except for 0.25 g L -1 and 5 g L -1 , which did not show 35 it is possible to classify a combination between a plant extract/phytochemical and an antibiotic as synergic if the log 10 reduction CFU cm -2 caused by the combination is significantly higher (P < 0.05) than the sum of reductions of individual treatments. In this case, the application of antibiotics at MIC did not promote any significant improvement over activity of the plant extract alone (P > 0.05). Afterwards, B. sempervirens MeOH extract was submitted to fractionation for the identification of the bioactive compounds. Among the subfractions obtained from the nBuOH fraction of B. sempervirens, through silica gel column, F1 and F2 were differentiated, showing antibiotic-potentiating activity (at 0.5 g L -1 , data not shown). Analysing the 1 H NMR for all the eight fractions obtained, it was possible to compare the spectra of the active fractions F1 and F2 with the non-active ones. Bearing in mind the similar activity, some signals were found in both fractions (Fig. 3) , which were not found in the non-active ones. The identification was carried out using our in-house library of NMR data of common metabolites. Based on characteristic methyl and olefinic signals it was possible to identify betulinic acid (Fig. 4) as a major component together with oleanane and ursane type terpenoids. Betulinic acid and other similar terpenoids − lupeol, betulin, hederagenin, ursolic acid and oleanolic acid − were tested for their antibacterial activity by microdilution technique as previously explained. Pentacyclic triterpenoids α-amyrin, betulinic acid and betulinaldehyde, and other related triterpenes such as imberbic acid, oleanolic acid, ursolic acid, ulsolic acid, rotundic acid and zeylasteral have been reported to possess antimicrobial activity against many bacterial species, especially Gram-positive, but also against Gram-negative. 36, 37 In this study, only oleanolic acid and ursolic acid showed MIC up to 120 mg L -1 , which was 62.5 and 15.6 mg L -1 , respectively, against S. aureus CECT976. After MIC determination, these terpenoids were evaluated in combination with antibiotics searching for a synergistic activity through checkerboard method ( Triterpenoids are widely distributed in the plant kingdom and their therapeutic activities (such as antibacterial, antiviral, antiulcer, anti-inflammatory and anticancer) have been described in numerous reports. Plenty studies were also initiated to identify the cellular targets and molecular mechanisms of triterpenoids. Besides their influence on bacterial gene expression, 43 cell autolysis and peptidoglycan turnover, 37 oleanolic acid and related compounds also seem to affect the formation and maintenance of biofilms. 44 Indeed, Please do not adjust margins
Please do not adjust margins terpenes are believed to influence the fatty acid composition of the cell membrane, and thus cell hydrophobicity, which can lead to biofilm eradication. 45 To confirm this, oleanolic acid, which caused the best antibiotic-potentiation in this study, was evaluated for its anti-biofilm activity against S. aureus CECT 976 biofilms. Fig. 5 shows the number of CFU cm -2 obtained after 1h exposure to oleanolic acid at ½ MIC, MIC and 2 × MIC as well as with antibiotics at MIC, individually and in combination. Oleanolic acid applied at ½ MIC, MIC and 2 × MIC caused high biofilm CFU reduction, 70, 81 and 85%, respectively. The combination between the antibiotics and oleanolic acid never promoted higher biofilm reductions than those obtained with oleanolic acid alone. The exception was the combination of ciprofloxacin (at MIC) with oleanolic acid (at ½ MIC), that showed to be significantly than oleanolic acid alone at the same concentration (82%, P < 0.05). However, diverse combinations achieved worst biofilm reductions than those obtained with oleanolic acid alone (P < 0.05): between oleanolic acid and erythromycin, between oleanolic acid (at MIC) and tetracycline (at MIC) and between oleanolic acid (at 2 × MIC) and ciprofloxacin (at MIC). One could expect that by combining antibiotics with a possible biofilm inhibitor, the outcome would be an improved therapeutic benefit. Nevertheless, probably by applying the combination in a preliminary stage of bacteria adhesion/biofilm formation, the combinations would be more effective, which would explain the potentiation observed. Kurek, et al. (2012) 40 also found synergistic antibacterial effects of oleanolic acid in combination with ampicillin against biofilms of S. aureus and S. epidermidis, and with oxacillin against biofilms of L. monocytogenes, S. epidermis and S. aureus. Ursolic acid was found to inhibit biofilm formation of MRSA by reducing amino acids metabolism and expression of adhesins, 46 to induce genes related to chemotaxis, mobility and heat shock response, and to repress genes that have functions in cysteine synthesis and sulfur metabolism.
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Conclusions
Restoring the activity of antibiotics that were already accepted and approved for clinical safety aspects, minimal toxicity and side effects, could thereby potentially reduce the costs associated to drug preclinical and clinical development. This strategy is possible by combining antibiotic with adjuvants that are able to inhibit drug-resistance mechanisms expressed by the pathogens. This study allowed to assess the potential of 28 different plant species to be used in co-therapies against S. 
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